Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer

Accuracy in the assessment of performance status by oncologists has not been well evaluated. We investigated possible discrepancies in the assessment of performance status among patients, nurses, and oncologists, and evaluated the prognostic importance of each assessment. Two hundred and six inpatie...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ando, M, Ando, Y, Hasegawa, Y, Shimokata, K, Minami, H, Wakai, K, Ohno, Y, Sakai, S
格式: Artigo
語言:English
出版: Nature Publishing Group 2001
主題:
Regular Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363970/
https://ncbi.nlm.nih.gov/pubmed/11742480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2162
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
id pubmed-2363970
record_format dspace
spelling pubmed-23639702009-09-10 Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer Ando, M Ando, Y Hasegawa, Y Shimokata, K Minami, H Wakai, K Ohno, Y Sakai, S Br J Cancer Regular Article Accuracy in the assessment of performance status by oncologists has not been well evaluated. We investigated possible discrepancies in the assessment of performance status among patients, nurses, and oncologists, and evaluated the prognostic importance of each assessment. Two hundred and six inpatients with inoperable, advanced non-small cell lung cancer were investigated prospectively. Weighted Kappa statistics for inter-observer agreement were 0.53 between oncologists and patients and 0.63 between oncologists and nurses. There was a significant difference among the assessments by the three groups (P < 0.001). Oncologists gave the healthiest performance status assessment, nurses an intermediate assessment, and patients the poorest. When included separately in the Cox model, the assessment by each group was significantly correlated with survival. However, the assessment by the patients themselves failed to distinguish survival of patients with performance status 1 and 2. Among the three models including patient-, nurse-, and oncologist-assessed PS, that including oncologist-assessed PS best fitted to the observed survival data. These results showed that the assessment by the patients themselves is different from those by the nurses and the oncologists and provided additional support for the use of the assessment by oncologists in clinical oncology. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-11 /pmc/articles/PMC2363970/ /pubmed/11742480 http://dx.doi.org/10.1054/bjoc.2001.2162 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
institution US National Library of Medicine
collection PubMed Central
language English
format Article
topic Regular Article
spellingShingle Regular Article
Ando, M
Ando, Y
Hasegawa, Y
Shimokata, K
Minami, H
Wakai, K
Ohno, Y
Sakai, S
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
description Accuracy in the assessment of performance status by oncologists has not been well evaluated. We investigated possible discrepancies in the assessment of performance status among patients, nurses, and oncologists, and evaluated the prognostic importance of each assessment. Two hundred and six inpatients with inoperable, advanced non-small cell lung cancer were investigated prospectively. Weighted Kappa statistics for inter-observer agreement were 0.53 between oncologists and patients and 0.63 between oncologists and nurses. There was a significant difference among the assessments by the three groups (P < 0.001). Oncologists gave the healthiest performance status assessment, nurses an intermediate assessment, and patients the poorest. When included separately in the Cox model, the assessment by each group was significantly correlated with survival. However, the assessment by the patients themselves failed to distinguish survival of patients with performance status 1 and 2. Among the three models including patient-, nurse-, and oncologist-assessed PS, that including oncologist-assessed PS best fitted to the observed survival data. These results showed that the assessment by the patients themselves is different from those by the nurses and the oncologists and provided additional support for the use of the assessment by oncologists in clinical oncology. © 2001 Cancer Research Campaign http://www.bjcancer.com
author Ando, M
Ando, Y
Hasegawa, Y
Shimokata, K
Minami, H
Wakai, K
Ohno, Y
Sakai, S
author_facet Ando, M
Ando, Y
Hasegawa, Y
Shimokata, K
Minami, H
Wakai, K
Ohno, Y
Sakai, S
author_sort Ando, M
title Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
title_short Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
title_full Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
title_fullStr Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
title_full_unstemmed Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
title_sort prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
publisher Nature Publishing Group
publisher_facet Nature Publishing Group
publishDate 2001
url https://ncbi.nlm.nih.gov/pmc/articles/PMC2363970/
https://ncbi.nlm.nih.gov/pubmed/11742480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2162
_version_ 1760580886357606400

相似書籍